Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?

PROCEPT BioRobotics TodayPRCTPROCEPT BioRobotics $64.60 +1.27 (+2.01%) 52-Week Range$ 24.83▼ $77.00Price Target$ 66.00Add to WatchlistSurgical robotics company PROCEPT BioRobotics Co. NASDAQ: PRCT developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia (BPH) among aging men. The company went public during the special purpose acquisition company (SPAC) mania in 2021. However, unlike most SPACs, PROCEPT has been able to maintain its stock price near the higher range of its trading ...